Page 22 - Aduhelm News Today

WASHINGTON (AP) — Sen. Bernie Sanders is asking the White House to cut back a big...

The premium increase is so Medicare will have a reserve prepared if the program formally grants coverage for the drug Aduhelm, Medicare said.

Sen. Bernie Sanders (I-Vt.) is calling on the Biden administration to delay an increase in Medicare premiums for 2022 that is tied in part to a controversial, pricey Alzheimer's drug.

Fierce Biotech profiles three women breaking barriers in Alzheimer's disease R&D at leading pharmaceutical companies. Today, Eli Lilly's donanemab launch leader Brandy Matthews.

The FDA's recent approval of a new drug, Aduhelm, to clear the formation of amyloid plaques in the brain is potentially good news for the six million Americans who suffer from Alzheimer's disease. But the drug's approval process has stirred controversy.

Aduhelm, the Alzheimer’s drug approved this summer in a process that led some FDA advisers to quit , is the subject of new controversy. A 75-year-old woman in Canada participating...

November is Alzheimer's Awareness Month and doctors continue to explore the effects of the new drug 'Aduhelm'.

Brigham and Women's Hospital is conducting the first human trial of an Alzheimer's nasal vaccine meant to prevent or slow the disease's progression.

Test your knowledge of this week’s health news.

Newly published safety data shows that 41 percent of patients in key clinical trials of the Alzheimer’s drug experienced brain bleeding or swelling, though many cases were asymptomatic.